Thailand Sepsis Diagnostics Market Size & Outlook

The sepsis diagnostics market in Thailand is expected to reach a projected revenue of US$ 4.2 million by 2030. A compound annual growth rate of 10% is expected of Thailand sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$2.0
Forecast, 2030 (US$M)
$4.2
CAGR, 2023 - 2030
9.7%
Report Coverage
Thailand

Thailand sepsis diagnostics market, 2018-2030 (US$M)

Thailand

Thailand sepsis diagnostics market highlights

  • The Thailand sepsis diagnostics market generated a revenue of USD 2.0 million in 2022 and is expected to reach USD 4.2 million by 2030.
  • The Thailand market is expected to grow at a CAGR of 10% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 2.0 million
Market revenue in 2030USD 4.2 million
Growth rate10% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, Thailand accounted for 0.2% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 77.2 million by 2030.

Blood culture media was the largest segment with a revenue share of 40% in 2022. Horizon Databook has segmented the Thailand sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


Sepsis represents a major public health challenge in Thailand, marked by a high incidence and substantial mortality rates. Addressing this issue requires the development & implementation of effective diagnostic tools to enhance patient outcomes and alleviate the overall burden of the condition.

The data from the National Library of Medicine reveals that the incidence of septic arthritis, a common complication of sepsis, exhibited a slight increase from 2018 to 2019.

These tests, generally performed in hospital laboratories, can face limitations in accessibility, particularly in rural or remote regions. Hence, there is a pressing need for more effective point-of-care diagnostic tools that can be utilized in primary care & emergency settings to facilitate early detection and prompt treatment of sepsis.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

Thailand sepsis diagnostics market size, by product, 2018-2030 (US$M)

Thailand Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

Thailand sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more